COVID-19 Global Rheumatology Alliance

COVID-19 Global Rheumatology Alliance
Name	COVID-19 Global Rheumatology Alliance
Formation	2020
Headquarters	Global
Fields	Rheumatology, Epidemiology, Immunology

COVID-19 Global Rheumatology Alliance is an international clinician- and researcher-led consortium established in 2020 to collect and analyze data on the effects of SARS-CoV-2 infection in patients with rheumatic diseases. The Alliance brought together experts from institutions such as Johns Hopkins University, University of Oxford, Harvard Medical School, Mayo Clinic, and University of Toronto to respond rapidly during the COVID-19 pandemic and to inform guidance from organizations like the World Health Organization and the Centers for Disease Control and Prevention.

Background

The Alliance was formed in the context of early uncertainty about risks for patients with autoimmune conditions, concurrent with public health responses from European Centre for Disease Prevention and Control, clinical guidance from the American College of Rheumatology, and regulatory actions by the U.S. Food and Drug Administration. Influential events such as the emergence of variants associated with SARS-CoV-2, reporting from healthcare systems in Wuhan, observational signals from specialty societies like the European League Against Rheumatism and policy debates in parliaments including the United Kingdom Parliament shaped the need for coordinated rheumatology-specific data collection.

Formation and Organization

Initiated by clinician-researchers affiliated with centers including Brigham and Women's Hospital, Vanderbilt University Medical Center, University College London, and Stanford University School of Medicine, the Alliance adopted an open, volunteer-driven structure similar to consortia like the Global Alliance for Genomics and Health and the International Severe Acute Respiratory and emerging Infection Consortium. Governance drew on models from foundations such as the Bill & Melinda Gates Foundation and advisory input from national academies including the National Academies of Sciences, Engineering, and Medicine. Organizational elements included steering committees, regional hubs in North America, Europe, Asia, and Africa, and working groups focused on data, biostatistics, and patient-reported outcomes.

Objectives and Activities

Primary objectives encompassed rapid case ascertainment, risk factor analysis, and aggregation of treatment outcomes to guide clinical decisions in settings represented by institutions like Cleveland Clinic and Mount Sinai Health System. Activities included maintaining registries, producing guidance used by the American College of Rheumatology and the European Alliance of Associations for Rheumatology, conducting cohort studies leveraging networks such as the Observational Health Data Sciences and Informatics community, and disseminating findings through journals like the New England Journal of Medicine, The Lancet, and Annals of the Rheumatic Diseases.

Research and Data Collection

The Alliance operated international physician-reported and patient-reported registries modeled after surveillance systems from the World Health Organization and data platforms used by UK Biobank and All of Us Research Program. Data harmonization employed standards from entities such as the International Classification of Diseases and analytic approaches informed by groups like the Global Burden of Disease Study team at the Institute for Health Metrics and Evaluation. The registries captured demographics, comorbidities, medication exposures (including biologics marketed by companies like AbbVie and Roche), and outcomes such as hospitalization and mortality, enabling pooled analyses with collaborators including the Centers for Medicare & Medicaid Services and national health services like the National Health Service (England).

Key Findings and Publications

Analyses published by Alliance investigators contributed evidence on risk modifiers such as glucocorticoid exposure, disease activity, and specific immunomodulatory therapies, informing updates by the American College of Rheumatology and guidance cited by the World Health Organization. Selected publications in peer-reviewed venues compared outcomes across regions including Italy, Spain, Brazil, and United States cohorts and were discussed in meetings of professional bodies like the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Findings influenced vaccine-position statements by organizations such as the Centers for Disease Control and Prevention and were referenced in systematic reviews conducted by teams at Cochrane.

Collaborations and Partnerships

The Alliance partnered with professional societies including the American College of Rheumatology, European Alliance of Associations for Rheumatology, and the Asia Pacific League of Associations for Rheumatology, and worked with registries and databases run by institutions like University of Oxford and consortia such as International Severe Acute Respiratory and emerging Infection Consortium. Cross-disciplinary collaborations involved immunologists from National Institutes of Health, epidemiologists from London School of Hygiene & Tropical Medicine, and patient advocacy organizations comparable to Arthritis Foundation and Versus Arthritis.

Impact on Clinical Practice and Policy

Outputs from the Alliance informed updates to clinical guidance used by rheumatologists at centers including Massachusetts General Hospital and policy discussions within agencies such as the U.S. Food and Drug Administration and regional health ministries. By providing granular data on medication-associated risks and vaccine responses, the Alliance influenced recommendations adopted by the American College of Rheumatology, aided shared decision-making in clinics affiliated with University of California, San Francisco, and contributed empirical evidence cited in health technology assessments by bodies analogous to the National Institute for Health and Care Excellence.

Category:Medical and health organizations Category:Rheumatology